Researchers found that cross-linking T cells with GPC3-positive tumor cells with a GPC3/CD3 bsAb mediated potent GPC3-dependent and concentration-dependent cytotoxicity in vitro and significantly inhibited tumor growth in murine xenograft models [151]. This evidence concerns the gene GPC3 and neoplasm.